Medical Journals

Fty720 Ameliorates Th1-mediated Colitis in Mice by Directly Affecting the Functional Activity of Cd4+cd25+ Regulatory T Cells.

Authors:
  • Daniel Carolin
  • Sartory Nico
  • Zahn Nadine
  • Geisslinger Gerd
  • Radeke Heinfried H
  • Stein Juergen M

From: First Department of Internal Medicine, Entwicklung und Sicherheit-ZAFES, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.

Journal of immunology (Baltimore, Md. : 1950)

  • Publish Date: Feb 2007
  • ISSN: 0022-1767
  • Volume: 178
  • Issue: 4
  • Pages: 2458-68
  • Medium: Print
  • Language: English
  • Citation (JAMA): Daniel Carolin, Sartory Nico, Zahn Nadine, et al. Fty720 Ameliorates Th1-mediated Colitis in Mice by Directly Affecting the Functional Activity of Cd4+cd25+ Regulatory T Cells.. J. Immunol. Feb 2007;178:2458-68

Abstract

Following the present concepts, the synthetic sphingosine analog of myriocin FTY720 alters migration and homing of lymphocytes via sphingosine 1-phosphate receptors. However, several studies indicate that the immunosuppressive properties of FTY720 may alternatively be due to tolerogenic activities via modulation of dendritic cell differentiation or based on direct effects on CD4(+)CD25(+) regulatory T cells (Treg). As Treg play an important role for the cure of inflammatory colitis, we used the Th1-mediated 2,4,6-trinitrobenzene sulfonic acid (TNBS) colitis model to address the therapeutic potential of FTY720 in vivo. A rectal enema of TNBS was given to BALB/c mice. FTY720 was administered i.p. from days 0 to 3 or 3 to 5. FTY720 substantially reduced all clinical, histopathologic, macroscopic, and microscopic parameters of colitis analyzed. The therapeutic effects of FTY720 were associated with a down-regulation of IL-12p70 and subsequent Th1 cytokines. Importantly, FTY720 treatment resulted in a prominent up-regulation of FoxP3, IL-10, TGFbeta, and CTLA4. Supporting the hypothesis that FTY720 directly affects functional activity of CD4(+)CD25(+) Treg, we measured a significant increase of CD25 and FoxP3 expression in isolated lamina propria CD4(+) T cells of FTY720-treated mice. The impact of FTY720 on Treg induction was further confirmed by concomitant in vivo blockade of CTLA4 or IL-10R which significantly abrogated its therapeutic activity. In conclusion, our data provide clear evidence that in addition to its well-established effects on migration FTY720 leads to a specific down-regulation of proinflammatory signals while simultaneously inducing functional activity of CD4(+)CD25(+) Treg. Thus, FTY720 may offer a promising new therapeutic strategy for the treatment of IBD.

Mesh Headings (Keywords): Animals, Antigens, CD, Antigens, Differentiation, Aziridines, Cell Differentiation, Choline, Colitis, Cytokines, Disease Models, Animal, Down-Regulation, Forkhead Transcription Factors, Immunosuppressive Agents, Inflammation, Inflammatory Bowel Diseases, Intestinal Mucosa, Male, Mice, Mice, Inbred BALB C, Neuromuscular Blocking Agents, Propylene Glycols, Sphingosine, T-Lymphocytes, Regulatory, Th1 Cells


Check for Full Text / PubMed Unique Identifier (PMID): 17277153


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.